Pulmonary artery pressure ‐guided therapy in ambulatory patients with symptomatic heart failure: the CardioMEMS European Monitoring Study for Heart Failure (MEMS‐HF)
ConclusionHaemodynamic ‐guided HF management proved feasible and safe in the health systems of Germany, The Netherlands, and Ireland. Physician‐directed treatment modifications based on remotely obtained PAP values were associated with fewer HFH, sustainable PAP decreases, marked KCCQ improvements, and remission of de pressive symptoms.Trial registration: ClinicalTrials.govIdentifier:NCT02693691
Source: European Journal of Heart Failure - Category: Cardiology Authors: Christiane E. Angermann,
Birgit Assmus,
Stefan D. Anker,
Folkert W. Asselbergs,
Johannes Brachmann,
Marie ‐Elena Brett,
Jasper J. Brugts,
Georg Ertl,
Greg Ginn,
Lutz Hilker,
Friedrich Koehler,
Stephan Rosenkranz,
Qian Zhou,
Philip B. Adamso Tags: Research Article Source Type: research
More News: Cardiology | Cardiomyopathy | Germany Health | Heart | Heart Failure | Ireland Health | Netherlands Health | Study | USA Health